A South African laboratory will soon produce a generic version of a groundbreaking HIV treatment, marking a major step toward medical self-reliance across the continent. Unitaid announced the development, highlighting its potential to expand access to advanced HIV care while reducing dependence on imported drugs. The treatment, known as lenacapavir and developed by US-based pharmaceutical